| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Astria Therapeutics, Inc. | Chief Business Officer | Stock Option (Right to Buy) | 262,500 | 21 Mar 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ATXS | Astria Therapeutics, Inc. | 21 Mar 2025 | 1 | $0 | 4 | Chief Business Officer | 25 Mar 2025, 16:07 |
| ATXS | Astria Therapeutics, Inc. | 08 Feb 2024 | 1 | $0 | 4 | Chief Business Officer | 12 Feb 2024, 16:05 |
| ATXS | Astria Therapeutics, Inc. | 02 Jun 2023 | 1 | $0 | 4 | Chief Business Officer | 06 Jun 2023, 08:08 |
| ATXS | Astria Therapeutics, Inc. | 17 Apr 2023 | 1 | $0 | 4 | Chief Business Officer | 19 Apr 2023, 08:10 |
| ATXS | Astria Therapeutics, Inc. | 17 Apr 2023 | 0 | $0 | 3 | Chief Business Officer | 19 Apr 2023, 08:09 |